Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion

International Ophthalmology

Volumn 29, Issue 5, 2009, Pages 343-348

  Astam, Neslihan ^a,b   Batioǧlu, Figen ^a   Özmert, Emin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Diabetic retinopathy; Intravitreal bevacizumab; Macular edema; Retinal vein occlusion

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADULT; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; ENDOPHTHALMITIS; EYE EXAMINATION; EYE INFLAMMATION; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; LASER COAGULATION; MALE; RECURRENT DISEASE; RETINA FOVEA; RETINA TEAR; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; THROMBOEMBOLISM; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 70349750575     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-008-9242-2     Document Type: Article

References (14)

1. Tranos PG, Pavesio CE (2004) Macular edema. Surv Ophthalmol 49(5):470-490
2. Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450
3. Gragoudas ES, Adamis AP et al (2004) VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular AMD. N Engl J Med 351:2805-2816
4. Avery RL, Pieramici DJ, Rabena MD et al (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372
5. Rosenfeld PJ, Fung AE, Puliafito CA (2005) OCT finding after intravitreal injection of bevacizumab for macular edema for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339
6. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) OCT findings after intravitreal injection of bevacizumab (Avastin) for neovascular age - related macular degeneration. Ophthalmic Surg Laser Imaging 36:270-271
7. Haritoglou C, Kook D, Neubauer A et al (2006) Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005
8. Iturralde D, Spaide R, Meyele C et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in CRVO. A short-term study. Retina 26:279-284
9. Shahar JS, Aury RL, Heilweil G et al (2006) Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab. Retina 26:262-269
10. Macugen Diabetic Retinopathy Study Group (2005) A phase II randomized double-masked study of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747-1757
11. Nguyen QD, Tatlipinar S, Mahmood S et al (2006) VEGF is a critical stimulus for diabetic macular edema. Am J Ophthalmol 142(6):961-969
12. Tolentino MJ, Miller JW, Gragoudas ES et al (1996) Intravitreous injections of VEGF produce retinal ischemia and microangiopathy in adult primate. Ophthalmology 103:1820-1828
13. Costa RA, Jorge R, Calucci D et al (2007) Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions. IbeVO study. Retina 27:141-148
14. Pai SA, Shetty R, Vijayan PB et al (2007) Clinical, anatomic and electrophysiologic eveluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 143:601-606